title: [Clinical application of diagnostic therapy of praziquantel for suspected cere- bral cysticercosis].
abstract: OBJECTIVE
  To explore the clinical application value of diagnostic therapy of praziquantel for suspected cerebral cysticercosis.
  
  
  METHODS
  The suspected cerebral cysticercosis patients were collected and treated with the diagnostic therapy [praziquantel, 50 mg/(kg · d)], and followed up for 1-2 years.
  
  
  RESULTS
  Totally 94 suspected cerebral cysticercosis patients were collected. After the diagnostic therapy, 78 (82.98%) cases were confirmed as cerebral cysticercosis, 13 (13.83%) were diagnosed as other diseases, and 3 (3.19%) were not definitely diagnosed.
  
  
  CONCLUSIONS
  The diagnostic therapy for suspected cerebral cysticercosis can reduce or avoid the missed diagnosis and misdiagnosis in some atypical cerebral cysticercosis patients.
authors.forename: Yan
authors.initials: Y
authors.lastname: Li
authors.forename: Li
authors.initials: L
authors.lastname: Sun
authors.forename: Chuang
authors.initials: C
authors.lastname: Chen
authors.forename: Chun-mei
authors.initials: CM
authors.lastname: Yang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003552:Cysticercus / Q000187:drug effects* / Q000502:physiology; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D020019:Neurocysticercosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000469:parasitology; D011223:Praziquantel / Q000627:therapeutic use*; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000871:Anthelmintics; D011223:Praziquantel